Scilex Holding SCLX
NASDAQ SCLX
$4.06 -0.35 (-7.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Return on Capital Employed [ROCE] (2022 - 2023)

Updated

Scilex Holding's Return on Capital Employed [ROCE] was -2940.51% in Q2 2023, down 2900.96 percentage points from -39.55% a year earlier and down 2630.18 percentage points from the prior quarter.

Analysis

Scilex Holding (SCLX) Return on Capital Employed [ROCE] (2022 - 2023) Analysis & Trends

For FY2022, Return on Capital Employed [ROCE] at Scilex Holding came in at -135.43%.

  • The Q2 2023 figure marks the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q2 2021.
  • Per Business Quant data, SCLX's Return on Capital Employed [ROCE] in the three quarters before Q2 2023 was -310.33% (Q1 2023), -103.02% (Q4 2022) and -54.61% (Q3 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Scilex Holding 28.56 Mn 16.54 Mn 3.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -2,940.51%
Mar 31, 2023 -310.33%
Dec 31, 2022 -103.02%
Sep 30, 2022 -54.61%
Jun 30, 2022 -39.55%
Mar 31, 2022 -40.65%
API Access

Scilex Holding Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SCLX&period=max&api_key=YOUR_API_KEY